Valproic Acid and All-Trans Retinoic Acid: Meta-Analysis of a Palliative Treatment Regimen in AML and MDS Patients

Publisher： Karger

E-ISSN： 2296-5262|31|11|629-633

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.31, Iss.11, 2008-10, pp. : 629-633

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insights into the All-trans-Retinoic Acid and Arsenic Trioxide Combination Treatment for Acute Promyelocytic Leukemia: A Meta-Analysis

By  

Acta Haematologica, Vol. 134, Iss. 2, 2015-04 ,pp. : 101-108

Karger

Access to resources Recommend Favorite

Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all‐trans retinoic acid and arsenic trioxide

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 4, 2015-11 ,pp. : 471-477

John Wiley & Sons Inc

Access to resources Recommend Favorite

All-Trans Retinoic Acid and Interferon-α for Treatment of Human Renal Cell Carcinoma Multicellular Tumor Spheroids

By  

Urologia Internationalis, Vol. 73, Iss. 1, 2008-06 ,pp. : 47-53

Karger

Access to resources Recommend Favorite

All‐trans retinoic acid and arsenic combination therapy benefits low‐to‐intermediate‐risk patients with newly diagnosed acute promyelocytic leukaemia: a long‐term follow‐up based on multivariate analysis

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 2, 2015-10 ,pp. : 277-280

John Wiley & Sons Inc

Access to resources Recommend Favorite

All‐trans retinoic acid and arsenic combination therapy benefits low‐to‐intermediate‐risk patients with newly diagnosed acute promyelocytic leukaemia: a long‐term follow‐up based on multivariate analysis

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 2015-10 ,pp. : 277-280

John Wiley & Sons Inc

Access to resources Recommend Favorite